Hepatology
Conference Coverage
HCV patients with early-stage hepatocellular carcinoma can achieve SVR
Among patients with hepatocellular carcinoma, rates of sustained viral response to direct-acting regimens for hepatitis C virus were 79% for...
Conference Coverage
Early TIPS effective in high-risk cirrhosis patients, but still underutilized
BOSTON – A new study confirms that high-risk cirrhosis patients treated early with a transjugular intrahepatic portosystemic shunt have increased...
Conference Coverage
Metabolomics of liquid biopsies offer a comprehensive look at NAFLD
BOSTON - Metabolomics of liquid biopsies noninvasively identified nonalcoholic fatty liver disease with and without steatosis, and assessed the...
Conference Coverage
Time to consider cirrhosis medical homes
Currently, there are no value-based models for hepatology in the United States. Cirrhosis medical homes could be one way to cut costs and improve...
Conference Coverage
VIDEO: Appealing DAA denials is worth it for hepatitis C patients
BOSTON – Though criteria for insurance approval for direct-acting antivirals for hepatitis C virus are loosening, many patients are still denied...
Conference Coverage
Sofosbuvir/velpatasvir improved patient-reported outcomes, knocked out HCV genotypes 1-6
BOSTON – When given with ribavirin, a fixed-dose combination of sofosbuvir/velpatasvir (Epclusa) achieved a sustained viral response at 12 weeks (...
Conference Coverage
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...
Conference Coverage
Direct-acting antiretrovirals in genotype 1 HCV patients with mental health conditions safe, well tolerated
Clinicians can feel confident treating genotype 1 hepatitis C virus patients with comorbid psychiatric conditions using direct-acting...
Conference Coverage
VIDEO: PBC patients with compensated cirrhosis fare well on obeticholic acid
BOSTON - Patients with primary biliary cholangitis who have compensated cirrhosis fared just as well on obeticholic acid as did primary biliary...
Conference Coverage
SNP predicts liver cancer in hepatitis C patients regardless of SVR
BOSTON
Conference Coverage
Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitis
Liver biopsy prior to treatment withdrawal in patients with well-controlled autoimmune hepatitis may be unnecessary, contrary to current...